
IVF and gender bias: Why are we still choosing boys?
A well-off, educated couple from Canada walked into my clinic last week, seeking consultation for in-vitro fertilization (IVF). 'After ten years of marriage, we've been yearning for a child and would value your guidance,' the wife said. It was a standard conversation—until she quietly added, 'I would like a male child.' Her husband, though slightly hesitant, nodded in agreement.
As a gynecologist, such requests are, unfortunately, not rare. IVF, while a medical marvel offering hope to countless childless couples, has also opened the door to something far more problematic: sex selection.
It prompts a painful question—why this persistent preference for boys?
From the operating table to the boardroom, women have proved themselves over and over. Whether it is medicine, law, aviation, science, or governance, women are thriving. They run countries, lead corporations, and redefine success across every domain. Yet, a slice of society continues to believe that a male child holds higher value—a belief not just outdated but dangerous.
In the Indian context, this preference has deep cultural roots. Traditionally, lineage and inheritance have been perceived as the domain of the male child. Whether it's lighting the funeral pyre or passing down the family name and business, the responsibility has always been reserved for sons. 'A father cannot exist without a mother,' I remind my patients, yet many still hesitate to envision a daughter performing these roles.
Underpinning these decisions are centuries-old expectations and pressures. Indian women are often burdened—silently or overtly—with the expectation of giving birth to a boy. I've seen couples devastated by the birth of a second girl. I've met women emotionally blackmailed—threatened with abandonment or divorce—because they failed to provide a 'male heir.' And I've had educated, affluent couples ask for male sex selection in IVF simply to appease family elders with ideas of inheritance and legacy.
To such couples, I ask: Why not a girl? Can't she lead your legacy, inherit your business, care for aging parents, and bring the same joy, prosperity, and pride? Yet, most often, my questions are met with awkward chuckles and patronizing smiles. We remain shackled by beliefs that a male child is central to carrying forward the family line—beliefs that desperately need to change.
Denied legal sex selection in India, many such couples head to international clinics in Dubai, Thailand, or Singapore, where the practice is not illegal, thus legitimizing their biased preferences. But regardless of venue or legality, the problematic sentiment remains the same.
Here in India, our laws are clear. The Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act, amended in 2003, strictly prohibits sex selection before or after conception. While illegal centers do continue to operate, the government has intensified scrutiny to curb this menace. However, this vigilance, while necessary, often leads to undue pressure on ethical doctors and innocent couples navigating the IVF journey the right way.
Beyond legal enforcement, however, we must shift mindsets. Education and public awareness campaigns should aim to dismantle these damaging beliefs. Legal reform alone won't suffice; societal expectations, especially those that quietly coerce women into choosing male offspring, must be publicly challenged.
Empowering women economically can create ripples of change.
IVF may be a gift of science, but how we choose to use it reveals who we are as a society. Until every child, regardless of gender, is equally welcomed and celebrated, the work remains unfinished.
(The writer is Dr. Rhythm Bhalla is a senior gynaecologist based in Chandigarh)

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Hindustan Times
an hour ago
- Hindustan Times
At what age should you first get your cholesterol checked? Cardiologist reveals: 'If you have a strong family history…'
Cholesterol is a type of lipid that your body needs to function. It forms part of your cell membranes, helps your liver make bile and serves as a building block for hormones. However, the problem arises when you have high levels of LDL cholesterol in your blood. This can lead to an increased risk of heart disease. Therefore, early detection is important, as it can often lead to you taking up life-changing measures. Most people check their cholesterol only when they have a problem. But the question is – when should one check their cholesterol for the first time?(Image by Freepik) Also Read | Cardiothoracic surgeon explains why young people are at risk of heart attack, cardiac arrest; can it be prevented? So, when should you get your cholesterol checked? What is the correct age to get it done for the first time? In an Instagram video post on July 22, Dr Naveen Bhamri, MD, DM (cardiology), revealed the right age to get your cholesterol checked for the first time. He wrote, 'Most people check their cholesterol only when they have a problem…But the question is – when should one check their cholesterol for the first time?' Let's find out what the doctor said. At what age should you first check your cholesterol levels? According to the cardiologist, the general recommendation suggests that a person should get their cholesterol checked at the age of 20 years, and it should be done with a fasting lipid profile. What if the data comes back normal? He said that if your tests show a normal number, then you should repeat the tests after 4-6 years. If you have a strong family history of heart disease, then get your cholesterol checked as early as possible. (Pexels) In case of high-risk patients… However, the story changes if you are a high-risk patient or have a family history. The cardiologist stressed that if you come under the high-risk category, for instance, you have a strong history of heart disease in your family, you have diabetes, you have high blood pressure, you are obese, you smoke regularly, you have PCOS (polycystic ovary syndrome), or you lead a sedentary lifestyle, then you should get your cholesterol checked as early as possible. He added that Indian guidelines say that one should get their first lipid profile done as early as the age of 12 years if they are obese and have a strong family history. 'So, lifestyle changes at an early age can prevent heart disease later,' Dr Bhamri added in the end. Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.


Hans India
an hour ago
- Hans India
Indian scientists develop new approach for treatment of liver cirrhosis
New Delhi: A team of Indian scientists has found a new way to treat liver cirrhosis, by targeting the lymphatic vessels in the liver and intestine that fail in case of cirrhosis. Chronic liver disease can progress from mild disease to fibrosis to cirrhosis (also known as scarring). Cirrhosis is accompanied by the distortion of both blood and lymphatic vessels in the liver and the intestine. Patients with advanced cirrhosis often develop complications like fluid accumulation in the abdomen. A team of scientists from the Institute of Liver and Biliary Sciences (ILBS), New Delhi, and National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, focussed on improving the drainage capacity of lymphatic vessels in the liver and intestine by using nanocarriers filled with a powerful protein called VEGF-C. 'Vascular endothelial growth factor-C (VEGF-C) is a key pro-lymphangiogenic factor that activates lymphangiogenesis or new lymphatic vessel growth. It does this through binding to a cell membrane tyrosine kinase receptor, vascular endothelial growth factor receptor-3 (VEGFR-3), the activation of which is essential for the growth and development of new lymphatic vessels,' said the researchers. The team probed the therapeutic efficacy of VEGF-C in ameliorating gut lymphatic dysfunction and improving lymph drainage. Owing to the hydrophilicity, short half-life, and systemic side effects of VEGF-C, the team led by Dr Subham Banerjee from NIPER Guwahati first focused on the development of VEGF-C encapsulated reverse micelle-based nanocarriers, which specifically bind to VEGFR-3 homodimers. Next, the ILBS team, led by Dr Savneet Kaur, tested the developed VEGF-C nanocarriers extensively in animal models of advanced cirrhosis and portal hypertension. The developed molecule was delivered via the oral route to ensure its gut lymphatic vessel uptake in the animal models. The team showed that VEGF-C nanocarriers significantly increased mesenteric lymph drainage, which reduced ascites. Importantly, the treatment also led to an attenuation of the portal pressures, improved cytotoxic T-cell immunity in mesenteric lymph nodes, and reduced local and systemic bacterial load. The research, published in the JHEP Reports journal, is the first to highlight that therapeutic lymphangiogenesis with VEGF-C is a promising treatment for reconstructing the fragmented lymphatic network and restoring lymphatic function and drainage in advanced cirrhosis.


Time of India
4 hours ago
- Time of India
5 more cases against Srushti Clinic head
Hyderabad: Gopalapuram police have registered five new cases against the head of Srushti Fertility Clinic Dr Athaluri Namratha alias Pachipala Namratha, and others based on complaints lodged by five sets of victims. While in one case a couple alleged that the doctor handed them a baby whose DNA did not match theirs, three other couples accused the clinic of adopting dubious methods. They claimed that they had already paid the money — anywhere from Rs 12.5 lakh to Rs 19 lakh — and even deposited their biological samples when they grew suspicious about the operations of Dr Namratha and her clinic. The frauds occurred between 2019 and 2025. Cops are yet to ascertain details of the fifth case. You Can Also Check: Hyderabad AQI | Weather in Hyderabad | Bank Holidays in Hyderabad | Public Holidays in Hyderabad Case 1: DNA mismatch causes trauma A woman from Hyderabad, requesting anonymity, alleged that she and her husband had approached Universal Srushti Fertility & Research Centre in July 2024 for infertility treatment. Dr Namratha advised gestational surrogacy using the couple's own genetic material and assured them that all legal formalities would be handled by them. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like American Investor Warren Buffett Recommends: 5 Books For Turning Your Life Around Blinkist: Warren Buffett's Reading List Undo The couple paid Rs 16.5 lakh for hormone therapy, laboratory work, and surrogate expenses. Their egg and sperm samples were collected at the clinic's Visakhapatnam branch on September 18, 2024. A baby girl was delivered via caesarean section on June 16, 2025, at a Visakhapatnam-based hospital. "Initially, we were told by the doctors that the baby was healthy, but they later shifted her to the NICU, terming her as late pre-term," the woman said. The couple's suspicions arose after Srushti staff refused to divulge the surrogate mother's details. Their fears deepened after they were unable to observe any facial resemblance with the baby, which prompted them to go for an independent DNA test. "The results, which came out on July 12, confirmed that neither of us was biologically related to the child," the complainant alleged. When confronted on July 22, Dr Namratha allegedly admitted that donor gametes were mistakenly used, and asked the couple to return the infant so the clinic could seek govt adoption clearance and repeat the procedure with their samples. The parents refused and approached the police, citing immense emotional trauma and legal uncertainty over the child's status. It is learnt that the child is still in the custody of the couple. The police have registered a case against Dr Namratha, Dr Vidyulatha, Kalyani, Sheshagiri, and Srinivasa Reddy under sections 61 (2), 316 (2), 318(4), 111, 335, 336, 340 BNS & Sections 38, 39, and 40 of the Surrogacy (Regulation) Act, 2021. Case 2: Rs 12.5 lakh lost in fraudulent surrogacy deal Another couple from the city approached police alleging they were duped of Rs 12.5 lakh by Dr Namratha and others through a fraudulent surrogacy deal. The husband, a 34-year-old private employee from the city, alleged that he and his wife approached Dr Namratha in Nov 2024 for a surrogate baby. Between April and May 2025, the couple paid Rs 10 lakh for tests and collection of 'biological samples' at the Secunderabad branch. On June 26, Dr Namratha allegedly informed them that the "baby is ready," indicating successful initiation of surrogacy, and collected Rs 2.5 lakh more. Though Dr Namratha assured that the baby would be delivered on February 3, 2026, the couple became suspicious when the hospital repeatedly refused to reveal the surrogate's identity, produce consent forms, or show proof of court permission, and decided to approach the police. A case was registered against Dr Namratha, her associates, Chenna Rao, and Sureka under relevant sections of BNS & the Surrogacy (Regulation) Act, 2021. Case 3: NRI couple loses Rs 19 lakh A US-based NRI couple who approached Universal Srushti Fertility and Research Centre in December 2019 for infertility treatment allegedly lost Rs 19 lakh to the accused. The husband, a 49-year-old software professional, and his wife approached Dr Namratha who, quoting a high success rate, charged Rs 7 lakh in cash and collected the couple's biological samples. After an unsuccessful embryo transfer, the couple returned to the USA. In January 2020, Dr Namratha advised the couple to opt for a surrogacy procedure costing Rs 25 lakh. The complainant's brother paid Rs 12 lakh in cash as an initial instalment. "The clinic provided no documents about medical procedures or statutory clearances. Due to Covid-19, I could not personally meet the doctor, and when I reached the fertility centre on Sunday, I came to know about the recent case against Dr Namratha," the complainant alleged. A case was registered against Dr Namratha under relevant sections of the BNS. Case 4: Nalgonda couple alleges Rs 11 lakh fraud A couple from Nalgonda alleged that Dr Namratha and her associates duped them of Rs 11 lakh with a false assurance of providing them with a child through a surrogacy procedure. The 49-year-old man and his wife first approached Universal Srushti Fertility Centre in June 2024 after unsuccessful IVF treatment attempts. Dr Namratha suggested surrogacy, and the couple paid Rs 9 lakh through UPI and Rs 2 lakh in cash between May 20 and July 2, 2025, and their samples were collected at the Secunderabad facility. "Despite the payments, the hospital neither produced proof of necessary legal permissions. They collected samples from us but did not start the surrogacy procedure," the complaint alleged. On learning about the other complaints against the facility, the victim approached the police on Sunday, and a case was registered against Dr Namratha, her associates, Archana, Dr Sadanandam, Chenna Rao, and Sureka under relevant Sections of the BNS.